Kestra Medical Technologies (NASDAQ:KMTS) Sets New 1-Year High – What’s Next?

Posted by Amy Steele on Apr 2nd, 2025

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS – Get Free Report) hit a new 52-week high during trading on Wednesday . The company traded as high as $26.06 and last traded at $25.57, with a volume of 88111 shares. The stock had previously closed at $24.58.

Analysts Set New Price Targets

KMTS has been the topic of a number of research analyst reports. Stifel Nicolaus initiated coverage on shares of Kestra Medical Technologies in a research report on Monday. They set a “buy” rating and a $28.00 price objective on the stock. Bank of America assumed coverage on Kestra Medical Technologies in a report on Monday. They set a “buy” rating and a $30.00 price target on the stock. Wells Fargo & Company assumed coverage on Kestra Medical Technologies in a report on Monday. They issued an “overweight” rating and a $28.00 price objective for the company. The Goldman Sachs Group assumed coverage on Kestra Medical Technologies in a research report on Monday. They issued a “neutral” rating and a $24.00 target price on the stock. Finally, Wolfe Research assumed coverage on shares of Kestra Medical Technologies in a research report on Monday. They set an “outperform” rating and a $29.00 price target for the company. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, Kestra Medical Technologies currently has an average rating of “Moderate Buy” and an average price target of $27.67.

Get Our Latest Analysis on KMTS

Kestra Medical Technologies Price Performance

Kestra Medical Technologies Company Profile

(Get Free Report)

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.